PubMed · 10214952
Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase.
Abstract
Reverse transcriptase of human immunodeficiency virus type I is a vitalenzyme in the HIV-1 replication cycle and an attractive target of attempts to arrest a primary viral infection. We designed a vector for eukaryotic expression of the 66 kDa subunit of reverse transcriptase under the control of the immediate early cytomegalovirus promoter. Efficient transient expression of the 66 kDa subunit of reverse transcriptase was achieved in a variety of cells. Immunostaining of the transfected cells revealed the cytoplasmatic localization of reverse transcriptase. Reverse transcriptase activity was detected in all transfected cell lines. Injection of this plasmid encoding the 66 kDa subunit of reverse transcriptase into mice resulted in strong reverse transcriptase-specific immune responses indicating that the 66 kDa subunit of reverse transcriptase is expressed in vivo. Sera from DNA-immunized mice inhibited reverse transcription in vitro.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M G Isaguliants, K Pokrovskaya, V I Kashuba, D Pokholok, J Hinkula, B Wahren, S N Kochetkov. 1999-03-26. Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase.. https://doi.org/10.1016/s0014-5793(99)00297-5
Cite the original work for its findings. Save a collection to share your selection of sources.